NCT03000387View on ClinicalTrials.gov

Personalized Dosing of Nicotine Replacement (NRT to Effect)

PHASE4CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

February 27, 2023

Study Completion Date

December 11, 2023

Conditions
Tobacco Use DisorderNicotine Dependence
Interventions
DRUG

Nicotine Patch

Active nicotine patch of 21 mg, 14 mg and 7 mg

DRUG

Placebos

Matching placebo patches of 21 mg, 14 mg and 7 mg

Trial Locations (2)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

M6J 1H4

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

collaborator

Ottawa Heart Institute Research Corporation

OTHER

lead

Centre for Addiction and Mental Health

OTHER

NCT03000387 - Personalized Dosing of Nicotine Replacement (NRT to Effect) | Biotech Hunter | Biotech Hunter